These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4275974)

  • 1. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC.
    Johnston RR; Way WL; Miller RD
    Anesthesiology; 1974 Jul; 41(1):57-61. PubMed ID: 4275974
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of dextroamphetamine and reserpine on halothane and cyclopropane anesthetic requirements.
    Johnston RR; White PF; Eger EI
    Anesth Analg; 1975; 54(5):655-9. PubMed ID: 1237254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 4. Central monoamines and antinociceptive drug action.
    Görlitz BD; Frey HH
    Eur J Pharmacol; 1972 Nov; 20(2):171-80. PubMed ID: 4265524
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of d-amphetamine and morphine upon the locomotor activity of mice treated with drugs which alter brain catecholamine content.
    Villarreal JE; Guzman M; Smith CB
    J Pharmacol Exp Ther; 1973 Oct; 187(1):1-7. PubMed ID: 4746328
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
    Scheel-Krüger J
    Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug interactions with brain biogenic amines and the effects of amphetamine isomers on locomotor activity.
    Zabik JE; Levine RM; Maickel RP
    Pharmacol Biochem Behav; 1978 Apr; 8(4):429-35. PubMed ID: 149988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of psychotropic drugs on tryptophan concentration in the rat brain.
    Tagliamonte A; Tagliamonte P; Perez-Cruet J; Stern S; Gessa GL
    J Pharmacol Exp Ther; 1971 Jun; 177(3):475-80. PubMed ID: 4328018
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of DL-p-chlorophenylalanine and DL-alpha-methyl-p-tyrosine on the brain catecholamine, serotonin and free amino acid contents in rat.
    Koyuncuoğlu H; Eroğlu L; Güngör M
    Psychopharmacologia; 1975 Dec; 45(2):163-6. PubMed ID: 129787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some observations on the circadian rhythm of locomotor activity of mice after depletion of cerebral monoamines.
    Hutchins DA; Rogers KJ
    Psychopharmacologia; 1973 Aug; 31(4):343-8. PubMed ID: 4270203
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 13. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of pentylenetetrazol and trimethadione on the metabolism of serotonin in brain and its relation to the anticonvulsant action of trimethadione.
    Diaz PM
    Neuropharmacology; 1974 Jul; 13(7):615-21. PubMed ID: 4280025
    [No Abstract]   [Full Text] [Related]  

  • 15. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 16. Central monaminergic neuronal effects on minimum alveolar concentrations (MAC) of halothane and cyclopropane in rats.
    Mueller RA; Smith RD; Spruill WA; Breese GR
    Anesthesiology; 1975 Feb; 42(2):143-52. PubMed ID: 1115362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomifensine and central monoamine neurons: histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1977; 29(5):509-19. PubMed ID: 145591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 19. Central transmitter involvement in LON-954-induced tremorogenesis.
    Coward DM; Doggett NS; Thomas JE
    Neuropharmacology; 1977; 16(7-8):479-84. PubMed ID: 144244
    [No Abstract]   [Full Text] [Related]  

  • 20. Reserpine and the monoaminergic regulation of adrenal dopamine beta-hydroxylase activity.
    Lima L; Sourkes TL
    Neuroscience; 1986; 17(1):235-45. PubMed ID: 2938024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.